Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Relationship between β-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women

Abstract

BACKGROUND AND AIMS: The β2-adrenergic receptors are important for adipocyte lipolysis regulation by catecholamines in humans. The β2-adrenoceptor gene is highly polymorphic. The role of these genetic variations for adipocyte lipolysis was investigated.

DESIGN AND METHODS: Six single-nucleotide polymorphisms (SNPs) in the promotor region and four SNPs in the coding region (leading to amino-acid substitution) of the β2-adrenoceptor gene were determined in 141 overweight or obese, but otherwise healthy women. Lipolysis experiments were performed on isolated subcutaneous adipocytes.

RESULTS: Three homozygous haplotypes (6/6, 4/4 and 2/2) were found that differed about 500-fold in noradrenaline sensitivity or β2-adrenoceptor sensitivity (6/6>2/2>4/4, P=0.01). The haplotypes also differed by 100% in maximum noradrenaline-induced lipolysis rates (6/6>2/2>4/4). However, there was no influence on β1-, β3- or α2A-adrenoceptor sensitivity. Heterozygosity at one or several SNPs in the haplotypes influenced the β2-adrenoceptor sensitivity significantly.

CONCLUSION: Multiple SNPs in the β2-adrenoceptor gene form several haplotypes that markedly influence β2-receptor function- and catecholamine-induced lipolysis in fat cells. These haplotypes may be important genetic factors behind impaired lipolysis in obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Large V, Arner P . Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes and hyperlipidemia. Diabetes Metab 1998; 24: 409–418.

    CAS  PubMed  Google Scholar 

  2. Reynisdottir S, Wahrenberg H, Carlström K, Rössner S, Arner P . Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors. Diabetologia 1994; 37: 428–435.

    Article  CAS  PubMed  Google Scholar 

  3. Carpene C, Bousqut-Melour A, Galitzky J, Galitzky J, Berlan M, Lafontan M . Lipolytic effects of beta1-, beta2- and beta3-adrenergic agonists in white adipose tissue of mammals. Ann NY Acad Sci 1998; 839: 186–189.

    Article  CAS  PubMed  Google Scholar 

  4. Liggett SB . Pharmacogenetics of beta1- and beta2-adrenergic receptors. Pharmacology 2000; 61: 167–173.

    Article  CAS  PubMed  Google Scholar 

  5. Green SA, Cole G, Jacinto M, Innis M, Liggett SB . A polymorphism of the human beta2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268: 23116–23121.

    CAS  PubMed  Google Scholar 

  6. Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human beta2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 3: 9414–9419.

    Article  Google Scholar 

  7. Green SA, Turki J, Bejarano P, Hall IP, Liggett SB . Influence of beta2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13: 25–33.

    Article  CAS  PubMed  Google Scholar 

  8. McGraw DW, Forbes SL, Kramer LA, Witte DP, Fortner CN, Paul RJ, Liggett SB . Polymorphisms of the 5′leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102: 1927–1932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Moore PE, Laporte JD, Abraham JH, Schwartzman IN, Yandava CN, Silverman ES, Drazen JM, Wand MP, Panettieri Jr RA, Shore SA . Polymorphism of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle. Am J Respir Crit Care Med 2000; 162: 2117–2124.

    Article  CAS  PubMed  Google Scholar 

  10. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P . Human beta2-adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta2-adrenoceptor function. J Clin Invest 1997; 100: 3005–3013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hoffstedt J, Iliadou A, Pedersen NL, Schalling M, Arner P . The effect of the beta(2)-adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 2001; 133: 708–712.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Scott MG, Swan C, Wheatly AP, Hall IP . Identification of novel polymorphism within the promoter region of the human beta2-adrenergic receptor gene. Br J Pharmacol 1999; 126: 841–844.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Drysdale CM, McGraw DW, Stephans JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB . Complex promoter and coding region beta2-adrenergic receptor haplotype alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483–10488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lafontan M, Berlan M . Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057–1091.

    CAS  PubMed  Google Scholar 

  15. Ek I, Arner P, Rydén M, Holm C, Thörne A, Hoffstedt J, Wahrenberg H . A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 2002; 51: 484–492.

    Article  CAS  PubMed  Google Scholar 

  16. Mauriege P, Imbeault P, Prud'Homme D, Tremblay A, Nadeua A, Despres JP . Subcutaneous adipose tissue metabolism at menopause: importance of body fatness and regional fat distribution. J Clin Endocrinol Metab 2000; 85: 2446–2454.

    CAS  PubMed  Google Scholar 

  17. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM . Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002; 87: 4166–4170.

    Article  CAS  PubMed  Google Scholar 

  18. Clark AG . Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 1990; 7: 111–122.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are indebted to Eva Sjölin, Britt-Marie Leijonhufvud, Katarina Hertel, Kerstin Wåhlén and Elisabeth Dungner for skilful assistance. This work was supported by grants from Swedish Research Coundil, Swedish Diabetes Association, Novo Nordic Foundation, Söderberg Foundation, Swedish Heart and Lung Foundation, the King Gustaf V and Queen Victorias Foundation and the Foundation for Old Servants, Thuring and Wiberg and the Swedish Society of Medicine.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Arner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eriksson, P., Dahlman, I., Rydén, M. et al. Relationship between β-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes 28, 185–190 (2004). https://doi.org/10.1038/sj.ijo.0802521

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802521

Keywords

This article is cited by

Search

Quick links